Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Effective use of naloxone among people who inject drugs in Kyrgyzstan and Tajikistan using pharmacy- and community-based distribution approaches.

Kan M, Gall JA, Latypov A, Gray R, Bakpayev M, Alisheva D, Rakhmatova K, Sadieva AS.

Int J Drug Policy. 2014 Nov;25(6):1221-6. doi: 10.1016/j.drugpo.2014.01.005. Epub 2014 Jan 23.

PMID:
24560486
2.
3.

Redressing the epidemics of opioid overdose and HIV among people who inject drugs in Central Asia: the need for a syndemic approach.

Gilbert L, Primbetova S, Nikitin D, Hunt T, Terlikbayeva A, Momenghalibaf A, Ruziev M, El-Bassel N.

Drug Alcohol Depend. 2013 Nov;132 Suppl 1:S56-60. doi: 10.1016/j.drugalcdep.2013.07.017. Epub 2013 Aug 13. Review.

4.

Engagement in a National Naloxone Programme among people who inject drugs.

McAuley A, Munro A, Bird SM, Hutchinson SJ, Goldberg DJ, Taylor A.

Drug Alcohol Depend. 2016 May 1;162:236-40. doi: 10.1016/j.drugalcdep.2016.02.031. Epub 2016 Mar 3.

PMID:
26965105
5.

High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.

Barocas JA, Baker L, Hull SJ, Stokes S, Westergaard RP.

Drug Alcohol Depend. 2015 Sep 1;154:283-6. doi: 10.1016/j.drugalcdep.2015.06.023. Epub 2015 Jun 24.

6.

The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.

Zaller ND, Yokell MA, Green TC, Gaggin J, Case P.

Subst Use Misuse. 2013 Jun;48(8):590-9. doi: 10.3109/10826084.2013.793355. Epub 2013 Jun 10.

PMID:
23750660
7.

Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability.

Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, Welch S, Gossop M.

Addiction. 1999 Feb;94(2):199-204.

PMID:
10396785
8.

Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.

Winter RJ, Stoové M, Degenhardt L, Hellard ME, Spelman T, Jenkinson R, McCarthy DR, Kinner SA.

Drug Alcohol Depend. 2015 Aug 1;153:43-9. doi: 10.1016/j.drugalcdep.2015.06.011. Epub 2015 Jun 16.

PMID:
26105708
9.

Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.

Green TC, Heimer R, Grau LE.

Addiction. 2008 Jun;103(6):979-89. doi: 10.1111/j.1360-0443.2008.02182.x. Epub 2008 Apr 16.

10.

Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario.

Leece PN, Hopkins S, Marshall C, Orkin A, Gassanov MA, Shahin RM.

Can J Public Health. 2013 Apr 18;104(3):e200-4.

PMID:
23823882
11.

Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.

Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, Ruiz S, Ozonoff A.

BMJ. 2013 Jan 30;346:f174. doi: 10.1136/bmj.f174.

12.

The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.

O'Halloran C, Cullen K, Njoroge J, Jessop L, Smith J, Hope V, Ncube F.

Int J Drug Policy. 2017 Aug;46:34-40. doi: 10.1016/j.drugpo.2017.05.017. Epub 2017 Jun 3.

PMID:
28586701
13.

Access to HIV counseling and testing among people who inject drugs in Central Asia: strategies for improving access and linkages to treatment and care.

Terlikbayeva A, Zhussupov B, Primbetova S, Gilbert L, Atabekov N, Giyasova G, Ruziev M, Soliev A, Saliev D, El-Bassel N.

Drug Alcohol Depend. 2013 Nov;132 Suppl 1:S61-4. doi: 10.1016/j.drugalcdep.2013.07.007. Epub 2013 Jul 31.

14.

Post-Soviet Central Asia: a summary of the drug situation.

Zabransky T, Mravcik V, Talu A, Jasaitis E.

Int J Drug Policy. 2014 Nov;25(6):1186-94. doi: 10.1016/j.drugpo.2014.05.004. Epub 2014 May 21.

PMID:
24954816
15.

Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.

Petersen Z, Myers B, van Hout MC, Plüddemann A, Parry C.

Harm Reduct J. 2013 Aug 19;10:13. doi: 10.1186/1477-7517-10-13.

16.

EMS runs for suspected opioid overdose: implications for surveillance and prevention.

Knowlton A, Weir BW, Hazzard F, Olsen Y, McWilliams J, Fields J, Gaasch W.

Prehosp Emerg Care. 2013 Jul-Sep;17(3):317-29. doi: 10.3109/10903127.2013.792888.

17.

Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan.

Zule WA, Latypov A, Otiashvili D, Kirtadze I, Ibragimov U, Bobashev GV.

Harm Reduct J. 2015 Oct 16;12:37. doi: 10.1186/s12954-015-0069-7.

19.

A systematic review of community opioid overdose prevention and naloxone distribution programs.

Clark AK, Wilder CM, Winstanley EL.

J Addict Med. 2014 May-Jun;8(3):153-63. doi: 10.1097/ADM.0000000000000034. Review.

PMID:
24874759
20.

Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.

Rowe C, Santos GM, Vittinghoff E, Wheeler E, Davidson P, Coffin PO.

Addiction. 2015 Aug;110(8):1301-10. doi: 10.1111/add.12961.

Supplemental Content

Support Center